Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
Open Access
- 1 January 1988
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 81 (1) , 213-220
- https://doi.org/10.1172/jci113298
Abstract
We examined plasma levels of the sympathetic neurotransmitter norepinephrine (NE) and its deaminated metabolite dihydroxyphenylglycol (DHPG) during supine rest in healthy human subjects and in sympathectomized patients, during physiological (tilt) or pharmacological (yohimbine, clonidine) manipulations known to affect sympathetically mediated NE release, during blockade of neuronal uptake of NE (uptake-1) using desipramine, and during intravenous infusion of NE. Healthy subjects had a mean arteriovenous increment in plasma DHPG in the arm (10%, P less than 0.05), whereas sympathectomized patients had a mean arteriovenous decrement in DHPG in the affected limb (mean decrease 21%, P less than 0.05 compared with healthy subjects). Tilt and yohimbine, which stimulate, and clonidine, which inhibits, release of endogenous NE, produced highly correlated changes in plasma NE and DHPG (r = 0.94). Pretreatment with desipramine abolished DHPG responses to yohimbine while enhancing NE responses. To attain a given increase in plasma DHPG, about a tenfold larger increment in arterial NE was required during NE infusion than during release of endogenous NE. When plasma NE was markedly suppressed after administration of clonidine, plasma DHPG decreased to a plateau level of 700-800 pg/ml. The results indicate that (i) plasma DHPG in humans is derived mainly from sympathetic nerves; (ii) increments in plasma DHPG during stimulation of NE release result from uptake of NE into sympathetic nerve endings and subsequent intraneuronal conversion to DHPG; (iii) plasma DHPG under basal conditions probably is determined mainly by net leakage of NE into the axonal cytoplasm from storage vesicles; and (iv) increments in NE concentrations at neuronal uptake sites can be estimated by simultaneous measurements of DHPG and NE during NE infusion and NE release. Measurement of NE and DHPG provides unique clinical information about sympathetic function.This publication has 29 references indexed in Scilit:
- Estimation of intrasynaptic norepinephrine concentrations in humans.Hypertension, 1986
- Indices of sympathetic vascular innervation in sympathectomized patientsJournal of the Autonomic Nervous System, 1986
- Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolismLife Sciences, 1985
- Measurement of regional neuronal removal of norepinephrine in man.Journal of Clinical Investigation, 1985
- Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromacytoma.Japanese Circulation Journal, 1985
- The effect of desmethylimipramine on the metabolism of norepinephrineLife Sciences, 1984
- Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.Journal of Clinical Investigation, 1983
- Radioenzymatic assay for plasma dihydroxyphenylglycol (DHPG), dihydroxymandelic acid (DOMA) and dihydroxyphenylacetic acid (DOPAC)Life Sciences, 1983
- Relationship between plasma norepinephrine and sympathetic neural activity.Hypertension, 1983
- Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary arteryNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977